Endometrial cancer and Second primary malignancy

Summary:

Second primary malignancy is found among people with Endometrial cancer, especially for people who are female, 60+ old.

The study analyzes which people have Second primary malignancy with Endometrial cancer. It is created by eHealthMe based on reports of 15 people who have Endometrial cancer from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Endometrial cancer?

Endometrial cancer is found to be associated with 551 drugs and 1,205 conditions by eHealthMe. Check the latest studies of Endometrial cancer.

What is Second primary malignancy?

Second primary malignancy (after getting cure a cancer, a new cancer development) is found to be associated with 538 drugs and 467 conditions by eHealthMe. Check the latest studies of Second primary malignancy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

15 people who have Endometrial Cancer and Second Primary Malignancy are studied.

Would you have Second primary malignancy when you have Endometrial cancer?

Gender of people who have Endometrial Cancer and experienced Second Primary Malignancy *:

female: 100 %
male: 0.0 %

Age of people who have Endometrial Cancer and experienced Second Primary Malignancy *:

Common co-existing conditions for these people *:

Oocyte Harvest: 1 person, 6.67%

Common drugs taken by these people *:

Common symptoms for these people *:

Acute Biphenotypic Leukaemia (leukaemia where the lineage is of both lymphoid and myeloid origin): 5 people, 33.33%
Ovarian Cancer (cancer of ovary): 3 people, 20.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 13.33%
Lymphoma Transformation (change in the nature of blood cell cancer): 2 people, 13.33%
Skin Cancer: 1 person, 6.67%
Metastases To Lung (cancer spreads to lung): 1 person, 6.67%
Lymphadenopathy Mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs): 1 person, 6.67%
Endometrial Cancer Recurrent: 1 person, 6.67%
Breast Cancer: 1 person, 6.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Second primary malignancy?

- Check whether Second primary malignancy is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Second primary malignancy and Endometrial cancer, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.